Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 061893
Company: DISTA
Company: DISTA
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| ILOSONE | ERYTHROMYCIN ESTOLATE | EQ 125MG BASE/5ML | FOR SUSPENSION;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 01/06/1975 | ORIG-1 | Approval |
Label is not available on this site. |
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
|---|---|---|---|---|---|
| 01/14/1991 | SUPPL-11 | Labeling |
Label is not available on this site. |
||
| 12/06/1991 | SUPPL-10 | Labeling |
Label is not available on this site. |
||
| 12/06/1991 | SUPPL-9 | Labeling |
Label is not available on this site. |